Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Ann Glob Health ; 88(1): 83, 2022.
Article in English | MEDLINE | ID: covidwho-2318543

ABSTRACT

The emergence and global spread of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is critical to understanding how to prevent or control a future viral pandemic. We review the tools used for this retrospective search, their limits, and results obtained from China, France, Italy and the USA. We examine possible scenarios for the emergence of SARS-CoV-2 in the human population. We consider the Chinese city of Wuhan where the first cases of atypical pneumonia were attributed to SARS-CoV-2 and from where the disease spread worldwide. Possible superspreading events include the Wuhan-based 7th Military World Games on October 18-27, 2019 and the Chinese New Year holidays from January 25 to February 2, 2020. Several clues point to an early regional circulation of SARS-CoV-2 in northern Italy (Lombardi) as soon as September/October 2019 and in France in November/December 2019, if not before. With the goal of preventing future pandemics, we call for additional retrospective studies designed to trace the origin of SARS-CoV-2.


Subject(s)
COVID-19 , COVID-19/epidemiology , China/epidemiology , Humans , Pandemics/prevention & control , Retrospective Studies , SARS-CoV-2
2.
Journal of the American College of Cardiology ; 81(8 Supplement):3821, 2023.
Article in English | EMBASE | ID: covidwho-2259992

ABSTRACT

Background Fulminant myocarditis can cause biventricular dysfunction with a mortality rate over 40%. We report a case with severe biventricular failure due to fulminant myocarditis that was successfully supported by left and right ventricular assist devices. Case A 65-year-old woman presented with chest pain, abdominal pain and diarrhea. She was hypotensive and labs revealed elevated troponin-T of 13.5 ng/mL and lactate of 4.3 mmol/L. She was positive for COVID by antigen testing. She was started on multiple vasopressor infusions and admitted to the intensive care unit. Echocardiogram revealed a severely reduced left ventricular ejection fraction of 15% and severe global hypokinesis. The following day, she developed a wide complex tachycardia that was refractory to amiodarone, lidocaine and multiple defibrillation attempts. She was transferred emergently to the cardiac cath lab where coronary angiography revealed an isolated 70% stenosis of the distal left circumflex artery. A Swan-Ganz catheter was placed that yielded a cardiac index by Fick of 1.2 L/min/m2, systemic vascular resistance of 1270 dynesseccm-5 and mixed venous oxygen saturation of 35%. Decision was made to emergently insert an Impella CP device. That evening, she developed complete heart block and transvenous pacing wire was inserted. Due to frequent suction alarms, decision was made to insert ProtekDuo device, which resulted in hemodynamic stabilization. A temporary coronary sinus pacing lead for atrial capture was inserted to improve atrioventricular synchrony. After several days of monitoring, repeat echocardiogram showed complete recovery of biventricular function and Impella CP and ProtekDuo devices were removed. Decision-making The decision of early implantation of ProtekDuo device was made to provide adequate blood flow to the left ventricular assist device for hemodynamic support. In addition, increased atrioventricular synchrony via insertion of temporary coronary sinus pacing wire improved cardiac output. Conclusion Fulminant myocarditis involving biventricular dysfunction can be supported by the use of simultaneous left and right ventricular assist devices.Copyright © 2023 American College of Cardiology Foundation

3.
Pan Afr Med J ; 41: 54, 2022.
Article in English | MEDLINE | ID: covidwho-2025477

ABSTRACT

Introduction: the response to COVID-19 pandemic has posed new obstacles to the fragile health system, most especially in the area of vaccination across much of Africa. As the response to the pandemic intensifies through the application of non-pharmacologic interventions as well as enforcement of the lockdowns across African cities, there is a significant risk that more children will miss out on life-saving vaccines that can prevent childhood killer diseases. This study was therefore conducted to look at the impact of the COVID-19 pandemic on routine immunization in Oyo State, Nigeria. Methods: we conducted a descriptive secondary analysis of immunization data between July 2019 and August 2020. These data were retrieved from the monitoring and evaluation unit of Oyo State Primary Health Care Board. The data were extracted from the original paper format and entered into Excel sheets. Line graphs were plotted to compare the trends of the coverage rates before and after the index case of the COVID-19 pandemic. Results: the average coverage rates for Bacillus Calmette-Guérin (BCG) before and after index case were 85.8% and 82.1% respectively, while it was 63.5% and 60.0% for HBV0. For the co-administered vaccines at 14 weeks, Penta 3, OPV 3, PCV 3 and IPV coverage rates dropped from 76.1%, 75.4%, 75.1% and 73.5% to 72.0%, 71.4%, 72.0% and 71.9% respectively. The average coverage rates for yellow fever and measles dropped sharply from 77.0% and 74.5% and 64.6% and 58.6% respectively. The average drop-out rates for the pre-and post-index case periods were 5.0% and 4.7% respectively. For the planned fixed and outreach sessions, none of the monthly sessions met the target of 100.0% in the post-index case period. Conclusion: decreased vaccination coverage for vaccine-preventable diseases could cause parallel outbreaks with COVID-19 and further exacerbate the strain on health systems attempting to end the acute phase of this pandemic. Therefore, as the dramatic second wave unfolds, the Government of Nigeria must take deliberate steps to strike a balance between a fresh lockdown and the imperative of uninterrupted social service. In this wise, it must remain committed to a timely vaccination program.


Subject(s)
COVID-19 , COVID-19/epidemiology , COVID-19/prevention & control , Child , Communicable Disease Control , Humans , Nigeria/epidemiology , Pandemics , Vaccination
4.
Journal of Community Medicine and Primary Health Care ; 34:58-68, 2022.
Article in English | Africa Wide Information | ID: covidwho-1970745

ABSTRACT

AJOL : Background: Coronavirus disease (COVID-19) is a fatal respiratory infection that has spread rapidly around the world since it was first discovered in China in late 2019. Several management options and experiences have been observed across health systems globally including Nigeria. We report the progression and evolving clinical scenario of the first case of COVID-19 in Delta State, Nigeria.Methods: We reviewed the hospital admission case record of the first case of COVID- 19 in a 50-year-old male managed at the isolation centre of the Delta State University Teaching Hospital, Oghara, Delta State. All relevant information about the patient's clinical characteristics, investigations, treatment and outcome were obtained and documented.Results: The patient was positive for COVID-19 and was placed on a wide-range of medications and supportive therapy. No baseline laboratory investigations were done throughout the period due to lack of a designated infectious disease laboratory to provide services at the time. Patient's overall wellbeing was based on physical assessment and monitoring of vital signs: temperature, pulse rate, respiratory rate, blood pressure and oxygen saturation (SPO2). Although he became symptom-free by the 12th day of admission, the laboratory report was persistently positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) until the 35th day of admission when he became negative.Conclusion: This report showed that the patient had complete resolution of clinical symptoms without concomitant viral clearance. Also, intensive supportive care contributed to a favourable outcome in this patient. The need for improved surveillance and response systems to ensure better patient outcome is recommended

5.
J Surg Educ ; 79(2): 426-430, 2022.
Article in English | MEDLINE | ID: covidwho-1747725

ABSTRACT

OBJECTIVE: Prior to 2015 residents in our Accreditation Council for Graduation Medical Education (ACGME) colon and rectal surgery training program were in charge of managing, with faculty oversight, the outpatient anorectal clinic at our institution. Starting in 2015 advanced practice providers (APPs) working in the division assumed management of the clinic. The effect of APPs on ACGME resident index diagnostic case volumes has not been explored. Herein we examine ACGME case log graduate statistics to determine if the inclusion of APPs into our anorectal clinic practice has negatively affected resident index diagnostic anorectal case volumes. DESIGN: ACGME year-end program reports were obtained for the years 2011 to 2019. Program anorectal diagnostic index volumes were recorded and compared to division volumes. Analysis of variance (ANOVA) and analysis of covariance (ANCOVA) tests were conducted to assess whether the number of cases per year (for each respective case type) prior to the introduction of APPs into the anorectal clinic (2011-2014) differed from the number of cases per year with the APP clinic in place (2015-2018). A p-value <0.05 was considered statistically significant. SETTING: Mayo Clinic, Rochester, Minnesota (quaternary referral center). PARTICIPANTS: Colon and rectal surgery resident year-end ACGME reports (2011-2019). RESULTS: ANOVAs revealed a marginally significant (p = 0.007) downtrend for hemorrhoid diagnostic codes, and a significant uptrend (p = 0.000) for fistula cases. Controlling for overall division volume, ANCOVA only reveled significance for fistula cases (p = 0.004) with the involvement of APPs. CONCLUSIONS: At our institution we found the inclusion of APPs into our anorectal clinic practice did not negatively affect colon and rectal surgery resident ACGME index diagnostic anorectal case volumes. Inclusion of APPs into a multidisciplinary practice can promote resident education by allowing trainees to pursue other educational opportunities without hindering ACGME index case volumes.


Subject(s)
Education, Medical , General Surgery , Internship and Residency , Accreditation , Clinical Competence , Colon , Education, Medical, Graduate , General Surgery/education , Humans
6.
Journal of Pediatric and Neonatal Individualized Medicine ; 11(1):12, 2022.
Article in English | Web of Science | ID: covidwho-1726743

ABSTRACT

Background: The epidemiological knowledge about the diffusion and diffusibility of SARS-CoV-2 in the pediatric population is constantly updated and revised, but not always based on sound and thorough body of evidence. This study examines the trend of the virus in the pediatric population in the Italian context. Specifically, it investigates the evidence available about the role of the pediatric population in the transmission of SARS-CoV-2. Methods: Analysis of the incidence of SARS-CoV-2 in Italy in the age group <= 19 years and comparison with other countries. Systematic reviews and meta-analysis available on PubMed regarding the infection rate of the pediatric population were analyzed. Results: In the period between July 2020 and November 2020, the new cases in the pediatric population show an exponential increase, revealing a rapid growth of new infections. In the literature there is a large amount of studies about the spread and transmission of SARS-CoV-2 in the pediatric population, but only few quantitative synthesis are available. The lack of data about the secondary attack rate of a pediatric index case in primary studies combined with the frequent lack of good methods makes it difficult to determine the infection rate in children. The analyzed literature shows that: a) the majority of pediatric cases comes from family transmission;b) the index case in the clusters is predominantly adults;c) pediatric index cases appear to be responsible for a lower secondary attack rate compared to adult index cases. Conclusion: We observed an exponential increase of SARS-CoV-2 cases in the age group between 0 and 19 years between July 2020 and November 2020 in Italy, but the international literature indicates that children do not transmit SARS-CoV-2 more than adults. However, the evidence is not sufficient to draw firm conclusions.

7.
Clin Infect Dis ; 71(16): 2222-2226, 2020 11 19.
Article in English | MEDLINE | ID: covidwho-1153139

ABSTRACT

This is the first known community transmission case of the novel coronavirus disease (COVID-19) in the United States, with significant public health implications. Diagnosis of COVID-19 is currently confirmed with PCR based testing of appropriate respiratory samples. Given the absence of travel or known exposure history, this patient did not meet the criteria for testing according to CDC guidelines at the time of her presentation. Since this case, any patient with severe disease (eg, ARDS or pneumonia) requiring hospitalization without an explanatory diagnosis can be tested even if no clear source of exposure is identified. While influencing national health policies for revising screening criteria, this case also highlighted significant knowledge gaps in diagnosis and treatment and a desperate need for early, widespread, fast and cheap testing for COVID-19.


Subject(s)
COVID-19/diagnostic imaging , Community-Acquired Infections/virology , Respiratory Distress Syndrome/virology , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/therapeutic use , Adult , Alanine/analogs & derivatives , Alanine/therapeutic use , Antiviral Agents/therapeutic use , COVID-19/complications , Community-Acquired Infections/drug therapy , Female , Humans , Middle Aged , Respiratory Distress Syndrome/diagnostic imaging , Risk Factors , Shock, Septic/etiology , Thorax/diagnostic imaging , Tomography, X-Ray Computed , Treatment Outcome , United States/epidemiology , COVID-19 Drug Treatment
8.
World J Methodol ; 11(1): 1-14, 2021 Jan 20.
Article in English | MEDLINE | ID: covidwho-1083724

ABSTRACT

BACKGROUND: In the ongoing coronavirus disease 2019 (COVID-19) pandemic, when children remain home-confined secondary to the closure of schools, little is known of the burden of the parents being their index case. AIM: To determine the prevalence of parents being the index case of COVID-19 infected children. METHODS: A database search in PubMed and Scopus ensued to recruit studies reporting the index case information of COVID-19 infected individuals aged ≤ 18. The reviewed articles' quality evaluation included the use of the National Heart, Lung, and Blood Institute's tool. A random-effect meta-analysis ensued to determine the prevalence of the parent being and not-being the index case. Heterogeneity was assessed by I 2 and Chi 2 statistics. The publication bias was evaluated by funnel plots and Egger's test. RESULTS: Overall, this review included 13 eligible studies sourcing data from 622 children of 33 nations. Study designs were heterogeneous and primarily included descriptive reports (38.4%). The prevalence of parent being the index case was 54% (95%CI: 0.29-0.79; I 2: 62.3%, Chi 2 P < 0.001). In > 70% of children, their index-case parent was symptomatic due to COVID-19 at the time of infection transmitting. Studies for which a risk of bias assessment was possible were of fair quality. CONCLUSION: There is a substantial global burden of parents being the index case of COVID-19 infected children, and frequently these parents are symptomatic. Therefore, from a public health perspective, early detection of these parents is crucial.

9.
J Infect Public Health ; 14(1): 61-65, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1065351

ABSTRACT

The concept of caseness in the COVID-19 virus is important for early case finding and reporting. These are essential steps for prevention and control. This review defines and differentiates between types of cases and specifies the elements of each case definition in general with their application to COVID-19, where appropriate. These terms and their application are useful for the surveillance team, epidemiologists, clinicians, policy makers as well as the public in general.


Subject(s)
COVID-19/epidemiology , SARS-CoV-2 , Epidemiological Monitoring , Global Health , Humans , Pandemics , World Health Organization
SELECTION OF CITATIONS
SEARCH DETAIL